# Bright Peak Therapeutics: Research, Basel, Switzerland

> Bright Peak Therapeutics: Bright Peak Therapeutics is a private biotechnology company founded in 2017, with headquarters in Basel/Allschwil, Switzerland...

Source: https://millionrounds.com/startup/bright-peak-therapeutics (Millionrounds; every figure on the page links to its filing or article)

Switzerland · [Research startup](https://millionrounds.com/companies)

# Bright Peak Therapeutics

Bright Peak Therapeutics is a private biotechnology company founded in 2017, with headquarters in Basel/Allschwil, Switzerland, and a presence in San Diego, California.

Funding reported Last round: Series C

Research Basel, Switzerland

Company summary

- **Founded:** 2017 9 years old
- **Team:** 33 11 to 50 people
- **Funding reported:** 232M as listed, currency not stated
- **Last round:** Series C Jun 2024

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Bright Peak Therapeutics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Bright Peak Therapeutics

Bright Peak Therapeutics is a private biotechnology company founded in 2017, with headquarters in Basel/Allschwil, Switzerland, and a presence in San Diego, California.

The company specializes in protein engineering to develop next-generation multifunctional immunotherapies aimed at treating cancer and autoimmune diseases. The core of Bright Peak's technology includes proprietary chemical protein synthesis, conjugation, and Enhanced Design and Combine (EDC) technology. This allows the company to engineer cytokines with optimized biological properties. Bright Peak is focused on creating a portfolio of first-in-class and best-in-class cytokines and multifunctional precision immunotherapies that precisely control immune activity. Their Bright Peak Immunocytokines combine antibody targeting with cytokine payloads for improved efficacy and reduced off-target effects. The company also refers to some of its engineered products as “duokines,” which involve the conjugation of cytokines. Bright Peak's pipeline includes designer immunotherapies and multifunctional PD-1 inhibitors, with a notable lead program being BPT567, a PD1-IL18 immunoconjugate for solid tumors. The company collaborates with partners, including Ajinomoto, to advance its innovative therapies.

## What company datasets say Bright Peak Therapeutics raised

Funding, as reported

Reported in all **232M** in the source's currency

Rounds **3**

Last round **Series C**

Last round size **90M**

Last round date **Jun 2024**

Investors listed **11**

## Founders and team

From Bright Peak Therapeutics's own website: 5 on the team.

- **Fredrik Wiklund** Chief Executive Officer
- **Robert Tam PhD** Vice President of Program Management
- **Vijaya Pattabiraman PhD** Chief Technology Officer
- **Izabela Zöger BSc** Board of Directors
- **John Schmid** Independent Director

## The company, in detail

What they build

Known for

health care bifunctional immunoconjugate immunotherapy pipeline biotechnology research immune response modulation medical research il-18 resistance protein engineering cis-signaling activation hospital & health care cancer immunotherapy medical clinical-stage biotech health chemical protein synthesis biotechnology

Built with from their website

Yoast SEO Backbone.js Google Tag Manager WordPress.org Ninja Forms PWA Font Awesome Viewport Meta Yoast Google Analytics

+8 more

WP Engine GoDaddy Domains Google Analytics 4 Wordpress Microsoft Exchange Online OpenAI Google Cloud Hosting jQuery Migrate

- **Sector:** Research
- **Industry code:** NAICS 541714, SIC 2834
- **Region:** Basel-Stadt
- **Revenue:** 1.7M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/bright-peak-therapeutics)

## Research in Switzerland

Startups like it

- [**Nouscom** Basel · founded 2015 *Raised*](https://millionrounds.com/company/nouscom)
- [**Hedera Dx** Epalinges · founded 2021 *Raised*](https://millionrounds.com/company/hedera-dx)
- [**Bio Protocol** Zug *Raised*](https://millionrounds.com/company/bio-protocol)
- [**InVirtuoLabs** Lugano · founded 2024 *Raised*](https://millionrounds.com/company/invirtuolabs)
- [**NEMIS Technologies** Waedenswil · founded 2018 *Raised*](https://millionrounds.com/company/nemis-technologies)
- [**Windward Bio** Basel](https://millionrounds.com/startup/windward-bio)
- [**Numab Therapeutics AG** Horgen · founded 2011](https://millionrounds.com/startup/numab-therapeutics-ag)
- [**Centenara Labs AG** Schlieren · founded 2019](https://millionrounds.com/startup/centenara-labs-ag)

## Is this your company?

Add your raise, your deck and your story, and put Bright Peak Therapeutics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)